Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: Protocol for a cohort study in Montreal, Canada

K Zinszer, B McKinnon, N Bourque, M Zahreddine, K Charland, J Papenburg, G Fortin, ME Hamelin, A Saucier, A Apostolatos, L Pierce, A Savard-Lamothe, Julie Carbonneau, P Conrod, N Haley, I Laurin, G Boivin, G De Serres, C Quach
doi: https://doi.org/10.1101/2021.04.14.21255499
K Zinszer
1School of Public Health, University of Montreal, Montreal, Quebec, Canada
2Centre for Public Health Research, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kate.zinszer@umontreal.ca
B McKinnon
1School of Public Health, University of Montreal, Montreal, Quebec, Canada
2Centre for Public Health Research, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N Bourque
1School of Public Health, University of Montreal, Montreal, Quebec, Canada
2Centre for Public Health Research, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Zahreddine
1School of Public Health, University of Montreal, Montreal, Quebec, Canada
2Centre for Public Health Research, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Charland
2Centre for Public Health Research, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Papenburg
3Montreal Children’s Hospital, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G Fortin
1School of Public Health, University of Montreal, Montreal, Quebec, Canada
2Centre for Public Health Research, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ME Hamelin
4Infectious Disease Research Centre, Laval University, Quebec City, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Saucier
1School of Public Health, University of Montreal, Montreal, Quebec, Canada
2Centre for Public Health Research, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Apostolatos
1School of Public Health, University of Montreal, Montreal, Quebec, Canada
2Centre for Public Health Research, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Pierce
1School of Public Health, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Savard-Lamothe
1School of Public Health, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Carbonneau
4Infectious Disease Research Centre, Laval University, Quebec City, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Conrod
1School of Public Health, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N Haley
7Direction régionale de la santé publique de Montréal du CIUSSS du Centre-Sud-de-l’Île-de-Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I Laurin
1School of Public Health, University of Montreal, Montreal, Quebec, Canada
7Direction régionale de la santé publique de Montréal du CIUSSS du Centre-Sud-de-l’Île-de-Montréal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G Boivin
4Infectious Disease Research Centre, Laval University, Quebec City, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G De Serres
8National Institute of Public Health of Quebec, Quebec City, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Quach
6Research Centre, Sainte-Justine University, Montreal, Quebec, Canada
9Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Further evidence is needed to understand the contribution of schools and daycares to the spread of COVID-19 in the context of diverse transmission dynamics and continually evolving public health interventions. The Enfants et COVID-19: Étude de séroprévalence (EnCORE) study will estimate the seroprevalence and seroconversion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among school and daycare children and personnel. In addition, the study will examine associations between seroprevalence and socio-demographic characteristics and reported COVID-19 symptoms and tests, and investigates changes in health, lifestyle and well-being outcomes.

Methods This study includes children and personnel from 62 schools and daycares in four neighbourhoods in Montreal, Canada. All children age 2-17 years attending one of the participating schools or daycares and their parents are invited to participate, as well as a sample of personnel members. Participants respond to brief questionnaires and provide blood samples, collected via dried blood spot (DBS), at baseline (October 2020-March 2021) and follow-up (May-June 2021). Questionnaires include socio-demographic and household characteristics, reported COVID-19 symptoms and tests, potential COVID-19 risk factors and prevention efforts, and health and lifestyle information. Logistic regression using generalized estimating equations will be used to estimate seroprevalence and seroconversion, accounting for school-level clustering.

Discussion The results of the EnCORE study will contribute to our knowledge about SARS-CoV-2 transmission in schools and daycares, which is critical for decisions regarding school attendance and the management of school outbreaks through the remainder of this school year and beyond.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study is funded by Public Health Agency of Canada through the COVID-19 Immunity Task Force. The funders had no role in the design of the study, data collection, analysis, interpretation of data, and writing of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the research ethics boards of the Université de Montréal (CERSES) and the Centre Hospitalier Universitaire Sainte-Justine. The study was also reviewed and approved by three of the participating school boards: Centre de services scolaire de Montreal, Centre de services scolaire Marguerite-Bourgeoys, and the English Montreal School Board and approved by two other participating school boards: Lester B. Pearson School Board and Centre de services scolaire de la Pointe-de-l’île. Written (electronically) informed consent is obtained from parents or legal guardians of participating children, while written assent (electronically) is obtained from participating children. Participating daycare and school personnel, as well as household members of seropositive children, also provide informed written consent (electronically).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The datasets generated during the current study will become publicly available upon completion of the study and will be available from the corresponding author on reasonable request.

  • List of abbreviations

    DBS
    Dried blood spot
    ELISA
    Enzyme-linked immunosorbent assay
    EnCORE
    Enfants et COVID-19: Étude de séroprévalence
    GAD-7
    Generalized Anxiety Disorder-7
    IgG
    Immunoglobulin G
    IMSE
    Indice de milieu socio-économique (Socio-economic index)
    MN
    Micro neutralization
    OD
    Optic density
    PHQ-9
    Patient Health Questionnaire-9
    PCR
    Polymerase chain reaction
    PRSP
    Programme Régionale de Santé Publique (regional public health program)
    RBD
    Receptor-binding domain
    SARS-CoV-2
    Severe acute respiratory syndrome coronavirus 2
    SDQ
    Strengths and Difficulties Questionnaire
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted April 16, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: Protocol for a cohort study in Montreal, Canada
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: Protocol for a cohort study in Montreal, Canada
    K Zinszer, B McKinnon, N Bourque, M Zahreddine, K Charland, J Papenburg, G Fortin, ME Hamelin, A Saucier, A Apostolatos, L Pierce, A Savard-Lamothe, Julie Carbonneau, P Conrod, N Haley, I Laurin, G Boivin, G De Serres, C Quach
    medRxiv 2021.04.14.21255499; doi: https://doi.org/10.1101/2021.04.14.21255499
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: Protocol for a cohort study in Montreal, Canada
    K Zinszer, B McKinnon, N Bourque, M Zahreddine, K Charland, J Papenburg, G Fortin, ME Hamelin, A Saucier, A Apostolatos, L Pierce, A Savard-Lamothe, Julie Carbonneau, P Conrod, N Haley, I Laurin, G Boivin, G De Serres, C Quach
    medRxiv 2021.04.14.21255499; doi: https://doi.org/10.1101/2021.04.14.21255499

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (271)
    • Allergy and Immunology (553)
    • Anesthesia (135)
    • Cardiovascular Medicine (1761)
    • Dentistry and Oral Medicine (238)
    • Dermatology (173)
    • Emergency Medicine (312)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (660)
    • Epidemiology (10803)
    • Forensic Medicine (8)
    • Gastroenterology (592)
    • Genetic and Genomic Medicine (2952)
    • Geriatric Medicine (287)
    • Health Economics (534)
    • Health Informatics (1930)
    • Health Policy (836)
    • Health Systems and Quality Improvement (745)
    • Hematology (293)
    • HIV/AIDS (631)
    • Infectious Diseases (except HIV/AIDS) (12519)
    • Intensive Care and Critical Care Medicine (693)
    • Medical Education (299)
    • Medical Ethics (86)
    • Nephrology (324)
    • Neurology (2801)
    • Nursing (151)
    • Nutrition (433)
    • Obstetrics and Gynecology (559)
    • Occupational and Environmental Health (597)
    • Oncology (1469)
    • Ophthalmology (444)
    • Orthopedics (172)
    • Otolaryngology (257)
    • Pain Medicine (190)
    • Palliative Medicine (56)
    • Pathology (381)
    • Pediatrics (867)
    • Pharmacology and Therapeutics (366)
    • Primary Care Research (337)
    • Psychiatry and Clinical Psychology (2641)
    • Public and Global Health (5374)
    • Radiology and Imaging (1013)
    • Rehabilitation Medicine and Physical Therapy (596)
    • Respiratory Medicine (726)
    • Rheumatology (330)
    • Sexual and Reproductive Health (289)
    • Sports Medicine (279)
    • Surgery (327)
    • Toxicology (47)
    • Transplantation (150)
    • Urology (125)